首页|DRGs付费背景下促进卒中中心合理用药管理

DRGs付费背景下促进卒中中心合理用药管理

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
以2022年6月-2023年12月卒中中心收治并纳入BR23病组的资料为数据来源，通过医院多个职能部门的联合干预，采用FOCUS-PDCA工具优化合理用药和DRGs相关指标。临床药师主要在合理用药宣讲、参与临床路径管理、医嘱审核、病例点评、药学服务、审查超支DRGs病组用药方案等方面进行合理用药管理。结果显示，与干预前相比，干预后的用药品种数、药占比、重点监控品种金额占比、住院天数、DRGs超支率、超支住院费用均下降(P<0。05)，国家基本药物金额占比提高(P<0。05)。
Promoting Rational Medication Management in the Stroke Center under DRGs Payment
Based on the data from cases admitted to the stroke center and included in the BR23 dis-ease group from June 2022 to December 2023,through collaborative interventions from various hospital de-partments,the FOCUS-PDCA tool was employed to optimize rational drug use and DRGs-related indicators.Clinical pharmacists mainly carried out rational drug use management through activities such as drug use advocacy,participation in clinical pathways management,prescription review,case evaluations,pharmaceuti-cal services and reviewing drug plans for DRGs with excessive expenditures.The results showed that com-pared to the pre-intervention period,the post-intervention period achieved decreases in the number of drug categories,drug expenditure ratio,proportion of expenditure on monitored drug categories,hospitalization day,DRGs overpayment rate,and overpayment inpatient expense(P<0.05);while the proportion of national essential drug expenditure increased(P<0.05).

Diagnosis related groupsStroke centerRational medication managementFOCUS-PDCAMedical insurance expense control

王钦、李文玲、徐新

展开 >

南通大学附属医院 药学部,南通 226001

疾病诊断相关分组 卒中中心 合理用药管理 FOCUS-PDCA 医保控费

江苏省医院协会医院管理创新研究课题江苏省药学会-天晴医院药学基金科研项目江苏省研究型医院学会精益化用药-石药专项科研基金项目

JSYGY-3-2021-147Q202130JY202241

2024

药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子：0.95
ISSN：1673-7806
年,卷(期)：2024.32(4)